Stockscreener 앱 받기
1.16
10.08%
-0.13
시간 외 거래:
1.16
전일 마감가:
$1.29
열려 있는:
$1.24
하루 거래량:
292.59K
Relative Volume:
0.25
시가총액:
$154.56M
수익:
-
순이익/손실:
$-18.86M
주가수익비율:
-0.0723
EPS:
-16.054
순현금흐름:
$-17.68M
1주 성능:
+16.00%
1개월 성능:
-55.56%
6개월 성능:
-42.29%
1년 성능:
-84.22%
1일 변동 폭
$1.13
$1.29
1주일 범위
$0.92
$1.58
52주 변동 폭
$0.92
$8.57
Indaptus Therapeutics Inc Stock (INDP) Company Profile
명칭
Indaptus Therapeutics Inc
전화
(646) 427-2727
주소
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
1.16 | 183.87M | 0 | -18.86M | -17.68M | -16.05 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Indaptus Therapeutics Inc 주식(INDP)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Indaptus Therapeutics Stock Price Forecast. Should You Buy INDP? - StockInvest.us
Indaptus Therapeutics Inc (NASDAQ: INDP) Share Price, INDP Stock News, INDP Share Price & Updates - Kalkine
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Declines By 64.1% - MarketBeat
Indaptus Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Indaptus Therapeutics Q2 EPS beats estimate as loss narrows - scanx.trade
Indaptus Therapeutics Reports Q2 Results Amid Strategic Pivot - TipRanks
Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary - TradingView
Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2 - Stock Titan
Indaptus Q2 Net Loss Narrows to $1.8 Million - Quiver Quantitative
Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise - Stock Titan
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics (INDP) Falls 14% to $1.02 — Biotech Micro-Cap Tests Critical SupportDescending Triangle - vinanet.vn
Indaptus net loss narrows 66% to $1.8 million in Q2 FY26 - Bitget
Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Indaptus Therapeutics (INDP) Q4 2025 Earnings: Wider-than-Expected Loss Amid No RevenueTax Rate Impact - vinanet.vn
Indaptus Therapeutics (INDP) to Announce Earnings on Monday - MarketBeat
Qinglai Lu Net Worth (2026) - GuruFocus
Indaptus Therapeutics Inc (INDP) Stock News Today - TradingKey
Indaptus Therapeutics (INDP) Slides 10.4% — Approaches Key Support at $1.23Dividend ETF - dars.gov.et
Indaptus Therapeutics (INDP) Slides 10.4% as Clinical-Stage Biotech Faces Selling PressureIchimoku Kumo Twist - Vinanet
INDP Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Down 20.88%EPS Surprise History - vinanet.vn
Indaptus Therapeutics Inc (INDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
INDP|Indaptus Therapeutics Inc|Price:2.610|Chg%:-0.160 - TradingKey
Indaptus Therapeutics Inc (INDP) Balance Sheet - TradingKey
Indaptus Therapeutics (INDP) Plunges 21% – Key Support Levels in FocusMFI Divergence - vinanet.vn
Indaptus Therapeutics Inc (INDP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Indaptus Therapeutics Inc (INDP) Cash Flow - TradingKey
Indaptus Therapeutics Market Sentiment - Benzinga España
Indaptus Therapeutics Inc (INDP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Indaptus Therapeutics Inc (INDP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
INDP|Indaptus Therapeutics Inc|Price:2.060|Chg%:-0.550 - TradingKey
Indaptus Therapeutics, Inc. Revenue Breakdown – NASDAQ:INDP - TradingView
Indaptus Therapeutics Inc (INDP) Institutional Confidence - TradingKey
TradingKey - TradingKey
INDP Q4 2025 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Faces Steep Stock DeclineConsensus Beat Rate - vinanet.vn
Indaptus Therapeutics Inc (INDP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INDP Q4 2025 Earnings: EPS Falls Short of Estimates, Stock Rises Amid Pipeline ProgressHigh Growth Earnings - vinanet.vn
Indaptus Therapeutics (INDP) Q3 2025 earnings summary - Quartr
Signal Proxy Intelligence Recommends Full Support for All Three Items at Indaptus Therapeutics, Inc. Annual Meeting - Nonstop Local News
Indaptus Therapeutics, Inc. SEC Filing (Jul 20, 2026) - Stock Titan
INDP Q4 2025 Earnings: EPS Misses Estimates Amid Continued R&D InvestmentOperating Margin Analysis - vinanet.vn
Indaptus Therapeutics (NASDAQ: INDP) seeks approval for 2026 equity plan - Stock Titan
INDP Q4 2025 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Navigates Clinical Development - vinanet.vn
Insider Traders Lose US$34k As Indaptus Therapeutics Drops - simplywall.st
INDP Q4 2025 Earnings: Wider-than-Expected Loss as Stock Declines Nearly 6%Revenue Estimate Trend - dars.gov.et
Indaptus Therapeutics Company Profile & Introduction - Moomoo
INDP Q4 2025 Earnings: EPS Misses Expectations Amid Zero Revenue; Stock Declines 1.96%Cost Structure Review - po-news-eg.net
Indaptus Therapeutics (INDP) News Flow - Moomoo
INDP Q4 2025 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Surprise Score - dars.gov.et
Form 13D/A Indaptus Therapeutics For: 26 June By Investing.com - Investing.com Australia
Indaptus Therapeutics Inc (INDP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):